Econlib Resources
|
TRACKBACKS (3 to date)
TrackBack URL: http://econlog.econlib.org/mt/mt-tb.cgi/106
The author at In the Pipeline in a related article titled I'll Have the Price They're Having writes:
COMMENTS (10 to date)
Robert Schwartz writes:
Marine Corps. Sir! Posted August 16, 2004 10:16 AM
DSpears writes:
"Would we be satisfied with a pharmaceutical industry of that caliber?" Once the government takes something over it won't matter if you are satisfied or not. Unless you think your 1/ten millionth of a vote in electing 4 out of 536 members of the government means that this new bureaucracy would be different from every other bureaucracy since the beginning of time. Posted August 16, 2004 11:01 AM
George writes:
My daughter tells me that funding for research that uncovered the tinman gene came mostly from non-governments sources. Posted August 16, 2004 11:38 AM
Lawrance George Lux writes:
When I think of a government-run utility, I think of Amtrak or the postal service. Would we be satisfied with a pharmaceutical industry of that caliber? Are there examples that are more positive? The Drug industry, I hope you notice I did not use pharmaceutical, stands as one of the greatest hypocrisies of all time. Ninty-five of all R&D costs consists not of finding an effective Drug, but in sufficiently altering existing Drugs to acquire the magical Patent. Doctors are recruited to push the new crap, though older medicines serving the same need effectively, can be had for a quarter of the Price of the new Drug. lgl Posted August 16, 2004 12:49 PM
Mcwop writes:
The government is not responsible for 100% of drug development. The pharma industry plays an important role (spending slightly more than the government), and nationalizing it would be a disaster. Currently, the government spends resources on "political diseases" (e.g. AIDS). If the government has complete control over drug development, then politics will dictate where the money is spent, and not disease incidence in society. The NIH spends on average about $700 per flu fatality. In contrast, it spends about $12,000 per Alzheimer's death, $14,000 per Parkinson's death and $158,000 per AIDS death. NIH spends $25 million a year on flu research, but it spends $79 million a year researching anthrax, which killed five people in 2001. Flu spending is so modest that it isn't listed on the NIH budgetary breakdown for disease spending. Flu deaths in U.S. 36,000 Posted August 16, 2004 12:55 PM
Mcwop writes:
The Drug industry, I hope you notice I did not use pharmaceutical, stands as one of the greatest hypocrisies of all time. Ninty-five of all R&D costs consists not of finding an effective Drug, but in sufficiently altering existing Drugs to acquire the magical Patent. Doctors are recruited to push the new crap, though older medicines serving the same need effectively, can be had for a quarter of the Price of the new Drug. lgl Please point to some supporting evidence for the 95% stat. I must take issue with minimalizing improvements to old drugs. I have a condition that can be treated with an old, cheap generic. Unfortunately that old generic has awful side effects, and over time many people develop allergies to it. The new medicine, which is more expensive by a factor of 10, has none of these side effects. This is the difference between showing up for work or not. I have to take this medicine every day for the rest of my life. Posted August 16, 2004 1:01 PM
Boonton writes:
Mcwop, your stats are one sided. Why should R&D spending be measured in dollars per death? How about R&D dollars per cost in medical expenses? In this case, AIDS and Alzheimer's would sensibly be given a lot of R&D weight since caring for those with it costs quite a bit while treating those with the flu (even those who die from it) is much less expensive. (AIDS here, BTW, has an added opportunity cost since it hits so many people who are young as opposed to old...robbing them and the economy of their peak years). By this metric R&D on anthrax & other bio-weapon diseases should be given almost no attention...yet common sense tells us that we should have good treatments for these diseases. Posted August 16, 2004 3:44 PM
Mcwop writes:
How about R&D dollars per cost in medical expenses? Lets take cancer then, which kills 564,000 people a year (just under 400,000 if you pull out lung cancer deaths that are preventable by not smoking). Cancer is very expensive to treat and effects young people as well. According to the CDC cancer incurs $64 billion in direct medical costs and more than $125 billion in lost productivity. Diabetes consumes 25% of the medicare budget, yet the NIH gives it 1/4 of the spending as AIDS. Posted August 16, 2004 5:06 PM
Boonton writes:
Cancer does effect young people but rarely. Economically AIDS is much more potent because it is both very expensive to treat and it hits people when they are very young. Unlike cancer, there is no theoretical limit to how many people AIDS can kill. Only so many people out of a 1000 will get cancer but there is no particular reason 1000 out of a 1000 could become infected with AIDS. I'm not saying that AIDS is not over represented in R&D budgets. I'm simply saying it is simplistic to assign weights on a single statistic such as how many people are killed per year by a particular disease. Posted August 17, 2004 12:16 PM
jason writes:
Boonton: "Only so many people out of a 1000 will get cancer but there is no particular reason 1000 out of a 1000 could become infected with AIDS." Behaviour. Aside from avoiding smoking most people can't dramatically reduce their risks of developing cancer at some point in their lives. AIDS (or rather the HIV virus), however, is almost impossible to get if you avoid a few risky behaviours. Posted August 23, 2004 11:05 AM
Comments for this entry
have been closed
|
||||||||
|
|
Blogging software: Powered by Movable Type 4.2.1.
Pictures courtesy of the authors. All opinions expressed on EconLog reflect those of the author or individual commenters, and do not necessarily represent the views or positions of the Library of Economics and Liberty (Econlib) website or its owner, Liberty Fund, Inc.
The cuneiform inscription in the Liberty Fund logo is the
earliest-known written appearance of the word
"freedom" (amagi), or "liberty." It
is taken from a clay document written about 2300 B.C. in the Sumerian city-state of Lagash.
|
||||||||